VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > News

<< Previous

Bullboard Posts

Next >>

Post by banderas1976on Feb 14, 2022 8:41am

397 Views

Post# 34425638

News

Attached is a special publication which appeared in the Toronto Star and distributed nationally this weekend as part of Heart Month - February series.

A focus this week was Congenital Heart Disease and Ventripoint received an endorsement from Allan Weatherall, Executive Director, Canadian Congenital Heart Alliance (CCHA).

The digital campaign landing page is here, and the digital article is here.

With our new Investor relations group, Iconic, we will be holding an investor update this week (see detail below). Please join if you can.

Regards,

Dr. George Adams ICD.D

Executive-Chairman

Ventripoint Diagnostics Ltd.

TSXV-VPT

www.ventripoint.com

519-803-6937

------------------------------------------------------------------

<< Previous

Bullboard Posts